KR950017968A - 인단 유도체 및 이의 제조방법 - Google Patents

인단 유도체 및 이의 제조방법 Download PDF

Info

Publication number
KR950017968A
KR950017968A KR1019940038059A KR19940038059A KR950017968A KR 950017968 A KR950017968 A KR 950017968A KR 1019940038059 A KR1019940038059 A KR 1019940038059A KR 19940038059 A KR19940038059 A KR 19940038059A KR 950017968 A KR950017968 A KR 950017968A
Authority
KR
South Korea
Prior art keywords
compound
indane
indan
pyridazine
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1019940038059A
Other languages
English (en)
Korean (ko)
Inventor
아끼히꼬 이시다
고이찌 혼마
미찌히사 야또
신수께 니시야마
후미까즈 오꾸무라
Original Assignee
지바따 이찌로
다나베세이야꾸 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 지바따 이찌로, 다나베세이야꾸 가부시끼가이샤 filed Critical 지바따 이찌로
Publication of KR950017968A publication Critical patent/KR950017968A/ko
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1019940038059A 1993-12-28 1994-12-28 인단 유도체 및 이의 제조방법 Ceased KR950017968A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP93-335250 1993-12-28
JP33525093 1993-12-28

Publications (1)

Publication Number Publication Date
KR950017968A true KR950017968A (ko) 1995-07-22

Family

ID=18286423

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019940038059A Ceased KR950017968A (ko) 1993-12-28 1994-12-28 인단 유도체 및 이의 제조방법

Country Status (11)

Country Link
US (1) US5686452A (https=)
EP (1) EP0661273B1 (https=)
KR (1) KR950017968A (https=)
CN (1) CN1107844A (https=)
AT (1) ATE180251T1 (https=)
CA (1) CA2138812A1 (https=)
DE (1) DE69418582D1 (https=)
DK (1) DK0661273T3 (https=)
MX (1) MX9500251A (https=)
SG (1) SG48755A1 (https=)
TW (1) TW288012B (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL118631A (en) * 1995-06-27 2002-05-23 Tanabe Seiyaku Co History of pyridazinone and processes for their preparation
US20040151759A1 (en) * 2002-08-16 2004-08-05 Douglas Cleverly Non-animal product containing veterinary formulations
WO2009142732A2 (en) * 2008-05-20 2009-11-26 Cephalon, Inc. Substituted pyridazinone derivatives as histamine-3 (h3) receptor ligands

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5179018A (en) * 1983-10-14 1993-01-12 Centocor, Inc. Mamalian monoclonal antibodies against endotoxin of gram-negative bacteria
US4816454A (en) * 1984-09-21 1989-03-28 Cassella Aktiengesellschaft 4,5-dihydro-3(2H)-pyridazinones and their pharmacological use
EP0194548A3 (de) * 1985-03-12 1988-08-17 Dr. Karl Thomae GmbH Neue Sulfonylaminoäthylverbindungen, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE3623944A1 (de) * 1986-07-16 1988-02-11 Thomae Gmbh Dr K Neue benzolsulfonamido-indanylverbindungen, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
IL88314A (en) * 1987-11-18 1994-05-30 Tanabe Seiyaku Co Sulphonylamino indane derivatives, their preparation and pharmaceutical compositions containing them
DK0589037T3 (da) * 1991-03-01 1996-09-16 Zeria Pharm Co Ltd Indanderivat og thromboxanantagonist indeholdende samme
CA2099743A1 (en) * 1992-07-02 1994-01-03 Akihiko Ishida Pyridazinone derivatives and processes for preparing the same
CA2139088A1 (en) * 1993-12-28 1995-06-29 Akihiko Ishida Indane derivatives, processes for preparing the same and synthetic intermediate of the same

Also Published As

Publication number Publication date
EP0661273B1 (en) 1999-05-19
US5686452A (en) 1997-11-11
CA2138812A1 (en) 1995-06-29
CN1107844A (zh) 1995-09-06
EP0661273A1 (en) 1995-07-05
SG48755A1 (en) 1998-05-18
DK0661273T3 (da) 1999-11-08
MX9500251A (es) 1997-04-30
TW288012B (https=) 1996-10-11
ATE180251T1 (de) 1999-06-15
DE69418582D1 (de) 1999-06-24

Similar Documents

Publication Publication Date Title
ATE131470T1 (de) Neue arylethenylenderivate und verfahren zu ihrer herstellung
ES2056913T3 (es) Derivados heterociclicos n-substituidos por el grupo benzhidrilo; su preparacion y su aplicacion.
KR960702460A (ko) 티아졸리딘디온 및 이것을 함유하는 약제(new thiazolidindiones and drugs containing them)
WO1991009857A1 (fr) Derives heterocycliques, leur procede de preparation et leur application therapeutique
ES8503667A1 (es) Un procedimiento para la preparacion de nuevos derivados de 2-oxo-imidazolina.
ATE161848T1 (de) Glycyrrheticsäurederivate
KR910021406A (ko) 축합 티아졸 화합물, 그의 제조 방법 및 용도
KR950702831A (ko) 심장 보호제(cardio-protective agent)
PT84881A (en) Process for the preparation of 4(5)-substituted imidazole derivatives
KR950017968A (ko) 인단 유도체 및 이의 제조방법
KR960014271A (ko) 디아릴디케토피롤로피롤 안료의 제조 방법
SE7601206L (sv) Acetylenderivat
NO178025C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive (benzhydryloksyetylpiperidyl)alifatiske syrederivater
EP0252720A3 (en) Pristinamycin process
IL44163A (en) Isoindoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
KR900003118A (ko) 술폰아미도시클로알칸화합물, 이것의 제조방법 및 이것을 함유하는 제약조성물
SE8505369D0 (sv) New thienopyridine derivatives, a process of preparation thereof and therapeutic compositions containing the same
KR880000451A (ko) 신규의 세펨 화합물, 그의 제조방법 및 용도
KR920009830A (ko) 신규 퓨린 유도체
JP2524420B2 (ja) ピペリジン誘導体及びそれらを有効成分とする抗潰瘍剤
KR890000478A (ko) 에르골린 유도체
DK626588A (da) Labile ketonderivater af 3-substituerede 1-alkylamino-2-propanoler og deres anvendelse som beta-adrenerge blokkere
HU895651D0 (en) Process for the preparation of substituted 3-amino-nonimine derivatives and pharmaceutical compositions containing said compounds
KR920016455A (ko) 신규한 퀴놀론화합물과 그 제조방법
GB1536195A (en) 3-phenyl-sec-butylamine derivatives

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

E601 Decision to refuse application
PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

R11 Change to the name of applicant or owner or transfer of ownership requested

Free format text: ST27 STATUS EVENT CODE: A-3-3-R10-R11-ASN-PN2301 (AS PROVIDED BY THE NATIONAL OFFICE)

R13 Change to the name of applicant or owner recorded

Free format text: ST27 STATUS EVENT CODE: A-3-3-R10-R13-ASN-PN2301 (AS PROVIDED BY THE NATIONAL OFFICE)